Dembe Allard E, Lynch Michele S, Gugiu P Cristian, Jackson Rebecca D
The Ohio State University, Columbus, OH, USA.
Eval Health Prof. 2014 Mar;37(1):50-70. doi: 10.1177/0163278713506112. Epub 2013 Sep 30.
Increasing emphasis is being placed on measuring return on research investment and determining the true impacts of biomedical research for medical practice and population health. This article describes initial progress on development of a new standardized tool for identifying and measuring impacts across research sites. The Translational Research Impact Scale (TRIS) is intended to provide a systematic approach to assessing impact levels using a set of 72 impact indicators organized into three broad research impact domains and nine subdomains. A validation process was conducted with input from a panel of 31 experts in translational research, who met to define and standardize the measurement of research impacts using the TRIS. Testing was performed to estimate the reliability of the experts' ratings. The reliability was found to be high (ranging from .75 to .94) in all of the domains and most of the subdomains. A weighting process was performed assigning item weights to the individual indicators, so that composite scores can be derived.
人们越来越重视衡量研究投资回报率，并确定生物医学研究对医疗实践和人群健康的真正影响。本文介绍了一种用于识别和衡量各研究地点影响的新标准化工具开发的初步进展。转化研究影响量表（TRIS）旨在提供一种系统方法，使用一组72个影响指标来评估影响水平，这些指标分为三个广泛的研究影响领域和九个子领域。在31名转化研究专家组成的小组的参与下进行了验证过程，他们开会定义并标准化了使用TRIS衡量研究影响的方法。进行了测试以估计专家评分的可靠性。在所有领域和大多数子领域中，可靠性都很高（范围从0.75到0.94）。进行了加权过程，为各个指标分配项目权重，以便得出综合分数。
